| Health / Medical Topics |
NA17 Peptide (Amino acid sequence VLPDVFIRCV)
A synthetic peptide vaccine derived from the melanoma antigen NA17. Dendritic cells (DC) harvested from a cancer patient may be exposed to or pulsed with the NA17 peptide (VLPDVFIRCV). Autologous vaccination with these altered dendritic cells may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for NA17, resulting in decreased tumor growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
Sodium ion requiring one electron to return to its elemental state.
A peptide cancer vaccine consisting of peptides derived from the melanoma antigen NA-17, the human leukocyte antigen HLA-A2-restricted human melanoma antigen 3…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N4 TNM finding…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3c TNM…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3b TNM…
A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3a TNM…
